F De Smedt

Papers

1

Total Citations

12

H-Index

1

About

F De Smedt is a leading clinical researcher in the field of neuro-oncology and radiosurgery, with a particular focus on the management of neurofibromatosis type 2 (NF2). Their most cited work, a 2013 study on hearing preservation and tumour control after Gamma Knife radiosurgery for NF2-related vestibular schwannomas, has garnered 12 citations and represents a critical contribution to the treatment of this challenging genetic condition. By analyzing outcomes from high-precision, robotized stereotactic irradiation, De Smedt demonstrated that radiosurgery can effectively control tumour growth while preserving cranial nerve function, offering a vital alternative to invasive surgery for patients with bilateral tumours. This research has helped shape clinical guidelines for NF2 management, balancing oncological control with quality of life. De Smedt’s work is essential reading for neurosurgeons, radiation oncologists, and researchers investigating the intersection of genetics and stereotactic radiation therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
12 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 4

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago